{
    "title": "AstraZeneca, Swiss firm Neurimmune ink $760 mln deal for antibody drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10563679/AstraZeneca-Swiss-firm-Neurimmune-ink-760-mln-deal-antibody-drug.html",
    "date": "2022-03-01",
    "keywords": [
        "firm",
        "condition",
        "heart",
        "drugmaker",
        "alexion",
        "treatment",
        "march",
        "plc",
        "therapy",
        "biotechnology",
        "neurimmune",
        "failure",
        "deal",
        "unit",
        "discovery",
        "drug",
        "aducanumab",
        "antibody",
        "transthyretin",
        "amyloid",
        "result",
        "blood",
        "agreement",
        "payment",
        "completion",
        "statement",
        "candidate",
        "class",
        "bodys",
        "protein",
        "astrazeneca",
        "portfolio",
        "success",
        "evusheld",
        "covid19",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}